Ven Bio Partners LLC Apellis Pharmaceuticals, Inc. Transaction History

Ven Bio Partners LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$31.4 - $69.84 $12.9 Million - $28.7 Million	-411,471 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$40.9 - $64.9 $3.23 Million - $5.13 Million	-79,000 Reduced 16.11%	411,471 $26 Million
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $342,169 - $635,663	-11,113 Reduced 2.22%	490,471 $28.1 Million
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $8.93 Million - $22.1 Million	-498,416 Reduced 49.84%	501,584 $13.4 Million
Q4 2019 May 20, 2020	BUY	$22.1 - $30.8 $22.1 Million - $30.8 Million	1,000,000 New	1,000,000 $30.6 Million
Q4 2019 Feb 13, 2020	SELL	$22.1 - $30.8 $22.1 Million - $30.8 Million	-1,000,000 Closed	0 $0
Q3 2019 May 20, 2020	BUY	$24.09 - $32.18 $24.1 Million - $32.2 Million	1,000,000 New	1,000,000 $24.1 Million
Q3 2019 Nov 14, 2019	SELL	$24.09 - $32.18 $24.1 Million - $32.2 Million	-1,000,000 Closed	0 $0
Q2 2019 May 20, 2020	BUY	$18.0 - $25.34 $18 Million - $25.3 Million	1,000,000 New	1,000,000 $25.3 Million
Q2 2019 Aug 14, 2019	SELL	$18.0 - $25.34 $27.5 Million - $38.7 Million	-1,526,122 Closed	0 $0
Q1 2019 May 20, 2020	BUY	$12.81 - $19.82 $19.5 Million - $30.2 Million	1,526,122 New	1,526,122 $29.8 Million
Q1 2019 May 15, 2019	SELL	$12.81 - $19.82 $22.9 Million - $35.5 Million	-1,790,102 Closed	0 $0
Q4 2018 May 26, 2020	BUY	$11.47 - $18.71 $20.5 Million - $33.5 Million	1,790,102 New	1,790,102 $23.6 Million

309

115M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.7B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Ven Bio Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Ven Bio Partners LLC with notifications on news.